CONMED Reports Strong Q4 2024 Revenue, Surpassing Wall Street Expectations
Feb 6, 2025
112
CONMED's Q4 2024 revenue surpassed expectations with a 5.8% rise, though full-year forecasts fell short. Despite stock setbacks, EPS growth suggests long-term potential for investors.